Biotechnology
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

$234.8M

Market Cap • 4/2/2025

2019

(6 years)

Founded

2022

(3 years ago)

IPO

NASDAQ

Listing Exchange

Flag of US

Cambridge

Headquarters • Massachusetts